Sun Pharma was at lifetime high yesterday at Rs 854. It has received final approval for Novartis's Reclast/Aclasta, which is used in the treatment of osteoporosis.
first published: Apr 3, 2013 03:12 pm
A collection of the most-viewed Moneycontrol videos.

U.S.-Iran Conflict Will Have Huge Impact On Global Markets, Businesses, Supply Chain: Nalin Mehta

Rising Bharat Summit 2026 | “Satellite Can Go Where Others Can’t” – Jyotiraditya Scindia

Rising Bharat Summit 2026 | “AI Creates More Opportunities” – Jyotiraditya Scindia

Rising Bharat Summit 2026 | Piyush Goyal Answers the Big India–US Trade Deal Question
You are already a Moneycontrol Pro user.

